Menasché P, Peynet J, Larivière J, Tronc F, Piwnica A, Bloch G, Tedgui A
Department of Cardiovascular Surgery, Hôpital Lariboisière, Paris, France.
Circulation. 1994 Nov;90(5 Pt 2):II275-9.
The use of warm blood cardioplegia is usually associated with that of warm cardiopulmonary bypass (CPB). Little is known, however, about the effect of temperature during bypass on neutrophil-endothelium interactions, which are currently considered a key component of the inflammatory response to CPB.
Twenty-five patients operated on under CPB were studied. Core temperature during bypass was kept normothermic (33.5 degrees C to 37 degrees C) in 14 and lowered to 28 degrees C to 30 degrees C in the 11 remaining patients. The two groups were otherwise comparable. Arterial blood samples were collected before CPB and 30 minutes, 4 hours, and 24 hours thereafter. Samples were assayed for interleukin-1 receptor antagonist (IL-1ra), soluble intercellular adhesion molecule 1 (sICAM-1), and elastase, which are markers of cytokine production, cytokine-upregulated endothelial ligands for neutrophil adhesion molecules, and degranulation secondary to adhesion of neutrophils to endothelial cells, respectively. IL-1ra levels (mean +/- SEM) peaked 4 hours after bypass and were significantly higher in the warm group (87,926 +/- 24,067 versus 18,090 +/- 5798 mg/L, P < .02). Peak values of sICAM-1, which occurred 24 hours after bypass, were correspondingly higher in warm patients (414 +/- 74 versus 298 +/- 23 micrograms/L in cold patients). In keeping with these data, warm patients released significantly more elastase at both the 30-minute (703 +/- 101 versus 349 +/- 55 micrograms/L, P < .01) and 4-hour (627 +/- 116 versus 324 +/- 31 micrograms/L, P < .03) post-CPB study points.
Temperature profoundly affects neutrophil-endothelium interactions, which leads one to question the use of systemic normothermia in patients at higher risk of suffering from postbypass inflammation-mediated organ damage.
温血心脏停搏液的使用通常与温心肺转流(CPB)相关。然而,关于转流期间温度对中性粒细胞与内皮细胞相互作用的影响知之甚少,而目前认为这种相互作用是CPB炎症反应的关键组成部分。
对25例接受CPB手术的患者进行了研究。14例患者在转流期间核心温度保持正常体温(33.5℃至37℃),其余11例患者的核心温度降至28℃至30℃。两组在其他方面具有可比性。在CPB前、CPB后30分钟、4小时和24小时采集动脉血样本。对样本进行白细胞介素-1受体拮抗剂(IL-1ra)、可溶性细胞间黏附分子1(sICAM-1)和弹性蛋白酶检测,它们分别是细胞因子产生、细胞因子上调的中性粒细胞黏附分子内皮配体以及中性粒细胞黏附于内皮细胞后脱颗粒的标志物。IL-1ra水平(均值±标准误)在转流后4小时达到峰值,且温血组显著更高(87,926±24,067对18,090±5798mg/L,P<.02)。sICAM-1的峰值出现在转流后24小时,温血患者相应更高(温血患者为414±74,冷血患者为298±23μg/L)。与这些数据一致,温血患者在CPB后30分钟(703±101对349±55μg/L,P<.01)和4小时(627±116对324±31μg/L,P<.03)时释放的弹性蛋白酶显著更多。
温度深刻影响中性粒细胞与内皮细胞的相互作用,这使得人们质疑在术后炎症介导的器官损伤风险较高的患者中使用全身正常体温的做法。